Suppr超能文献

肝细胞癌病因对切除术后生存的影响

INFLUENCE OF HEPATOCELLULAR CARCINOMA ETIOLOGY IN THE SURVIVAL AFTER RESECTION.

作者信息

Lopes Felipe de Lucena Moreira, Coelho Fabricio Ferreira, Kruger Jaime Arthur Pirolla, Fonseca Gilton Marques, Araujo Raphael Leonardo Cunha de, Jeismann Vagner Birk, Herman Paulo

机构信息

Liver Unit, Department of Gastroenterology, University of São Paulo Medical School, São Paulo, SP, Brazil.

出版信息

Arq Bras Cir Dig. 2016 Apr-Jun;29(2):105-8. doi: 10.1590/0102-6720201600020010.

Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer and its incidence is increasing around the world in the last decades, making it the third cause of death by cancer in the world. Hepatic resection is one of the most effective treatments for HCC with five-year survival rates from 50-70%, especially for patients with a single nodule and preserved liver function. Some studies have shown a worse prognosis for HCC patients whose etiology is viral. That brings us to the question about the existence of a difference between the various causes of HCC and its prognosis.

AIM

To compare the prognosis (overall and disease-free survival at five years) of patients undergoing hepatectomy for the treatment of HCC with respect to various causes of liver disease.

METHOD

Was performed a review of medical records of patients undergoing hepatectomy between 2000 and 2014 for the treatment of HCC. They were divided into groups according to the cause of liver disease, followed by overall and disease-free survival analysis for comparison.

RESULTS

There was no statistically significant difference in the outcomes of the groups of patients divided according to the etiology of HCC. Overall and disease-free survival at five years of the patients in this sample were 49.9% and 40.7%, respectively.

CONCLUSION

From the data of this sample, was verified that there was no prognostic differences among the groups of HCC patients of the various etiologies.

摘要

背景

肝细胞癌(HCC)是最常见的原发性肝癌类型,在过去几十年中其发病率在全球范围内呈上升趋势,使其成为全球癌症死亡的第三大原因。肝切除术是治疗HCC最有效的方法之一,五年生存率为50%-70%,尤其适用于单个结节且肝功能良好的患者。一些研究表明,病因是病毒感染的HCC患者预后较差。这就引出了一个问题,即HCC的各种病因与其预后之间是否存在差异。

目的

比较因各种肝病病因接受肝切除术治疗HCC患者的预后(五年总生存率和无病生存率)。

方法

对2000年至2014年间因治疗HCC而接受肝切除术的患者的病历进行回顾。根据肝病病因将他们分组,然后进行总生存率和无病生存率分析以作比较。

结果

根据HCC病因分组的患者组间结果无统计学显著差异。该样本中患者的五年总生存率和无病生存率分别为49.9%和40.7%。

结论

从该样本数据验证,不同病因的HCC患者组间不存在预后差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a3/4944746/13dc06b00cfe/0102-6720-abcd-29-02-00105-gf1.jpg

相似文献

1
INFLUENCE OF HEPATOCELLULAR CARCINOMA ETIOLOGY IN THE SURVIVAL AFTER RESECTION.
Arq Bras Cir Dig. 2016 Apr-Jun;29(2):105-8. doi: 10.1590/0102-6720201600020010.
5
[Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
Zentralbl Chir. 2009 Apr;134(2):127-35. doi: 10.1055/s-0028-1098881. Epub 2009 Apr 20.
6
Efficacy of major hepatectomy for large hepatocellular carcinoma.
Hepatogastroenterology. 2009 May-Jun;56(91-92):768-72.
7
Liver resection for hepatocellular carcinoma in oldest old patients.
World J Surg Oncol. 2019 Jan 3;17(1):1. doi: 10.1186/s12957-018-1541-0.
9
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.
10
Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
World J Surg Oncol. 2017 Aug 22;15(1):156. doi: 10.1186/s12957-017-1229-x.

引用本文的文献

2
Is tumor necrosis a clinical prognostic factor in hepato-biliary-pancreatic cancers? A systematic review and meta-analysis.
Cancer Med. 2023 May;12(10):11166-11176. doi: 10.1002/cam4.5742. Epub 2023 Mar 23.
3
Current status and future perspectives of radiomics in hepatocellular carcinoma.
World J Gastroenterol. 2023 Jan 7;29(1):43-60. doi: 10.3748/wjg.v29.i1.43.
5
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
6
Photodynamic therapy of extrahepatic cholangiocarcinoma using digital cholangioscopy.
Arq Bras Cir Dig. 2020 Nov 13;33(1):e1490. doi: 10.1590/0102-672020190001e1490. eCollection 2020.
7
Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis.
Hepatol Commun. 2020 Aug 9;4(10):1541-1551. doi: 10.1002/hep4.1564. eCollection 2020 Oct.
8
HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT.
Arq Bras Cir Dig. 2017 Oct-Dec;30(4):272-278. doi: 10.1590/0102-6720201700040011.
9
CRITICAL EVALUATION OF LONG-TERM RESULTS OF MALIGNANT HEPATIC TUMORS TREATED BY MEANS CURATIVE LAPAROSCOPIC HEPATECTOMY.
Arq Bras Cir Dig. 2017 Jul-Sep;30(3):205-210. doi: 10.1590/0102-6720201700030010.
10
High expression of Snail and NF-κB predicts poor survival in Chinese hepatocellular carcinoma patients.
Oncotarget. 2017 Jan 17;8(3):4543-4548. doi: 10.18632/oncotarget.13891.

本文引用的文献

2
COMPARISON OF HEPATIC PROFILE IN PRE AND POSTOPERATIVE OF BARIATRIC SURGERY: PRIVATE VS PUBLIC NETWORK.
Arq Bras Cir Dig. 2015 Nov-Dec;28(4):274-7. doi: 10.1590/S0102-6720201500040014.
3
The introduction of navigation in liver surgery in Brazil.
Rev Col Bras Cir. 2014 Nov-Dec;41(6):451-4. doi: 10.1590/0100-69912014006012.
4
Totally laparoscopic liver resection: new Brazilian experience.
Arq Bras Cir Dig. 2014 Jul-Sep;27(3):191-5. doi: 10.1590/s0102-67202014000300008.
7
Hepatectomy: a critical analysis on expansion of the indications.
Arq Bras Cir Dig. 2014 Jan-Mar;27(1):47-52. doi: 10.1590/s0102-67202014000100012.
8
[Laparoscopic hepatectomy with radiofrequency device].
Rev Col Bras Cir. 2013 Mar-Apr;40(2):160-3. doi: 10.1590/s0100-69912013000200014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验